Get this report today!
Table of Contents
The aim of this research service is to thoroughly assess and analyse the in vitro diagnostics market in Western European countries and provide strategic recommendations and conclusions for the success of market participants. This study provides an understanding of the key segments (immunochemistry, microbiology, molecular diagnostics, POCT, SMBG, tissue diagnostics, haematology and haemostasis), likely future trends, revenue forecasts and competitive analyses. It also provides an analysis of the IVD markets in the United Kingdom, Germany, France, Italy, Spain, Benelux (Belgium, the Netherlands and Luxembourg) and Scandinavia (Denmark, Norway, Sweden and Finland).
•The Western European IVD market is expected to continue growing from $xx,xxx.x million in 2011 to $xx,xxx.x million in 2018 at a compound annual growth rate (CAGR) of x.x per cent.
•Existing competitors have realised the market potential, and they take steps to constantly improve their products and services in emerging segments such as molecular diagnostics and point-of-care testing (POCT).
•Large international companies such as Roche, Siemens and Abbott dominate the market. This trend is predicted to continue.
•The market may witness an increase in competition, partnerships, licence agreements and mergers.
•Increasing trend of industry consolidation may witness large international companies with marketing expertise acquiring smaller companies and new entrants with R&D and technology expertise.
•The IVD market is technology driven. Increasing demand for IVD testing will require improved products and long-term post-sales service.
•Market participants may need to develop solutions best suited for customer needs to remain competitive.
•Due to the high competition and rising costs of diagnostic products and services, improved sales and market strategies are required, along with long-term partnerships with companies.
Talk to Robyn
+1 718 213 4904
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts Summary Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause ...
INTRODUCTION BCC Research measures and segments the flow cytometry market on the basis of instruments, reagents, software, services, technologies, applications and end users. Key instruments discussed ...
Enteric Disease Testing Market (Amebiasis, C.Difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.Coli Infection, Giardiasis, H.Pylori Infection, Norovirus Infection, Rotavirus Infection, ...
... Colposcopy repeat hpv + pap after 12 months referral to a general practitioner for extra sample: pap smear extra sampling step after hpv+ test should be avoided dna delphi self- sample molecular triage ...
... Contracted over the first six months, impacted by weak demand in southern europe and the consolidation of clinical laboratories in france. After a particularly challenging first quarter ...
Reportlinker.com © Copyright 2013. All rights reserved.